These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7726532)

  • 1. Fluconazole penetration into the human prostate.
    Finley RW; Cleary JD; Goolsby J; Chapman SW
    Antimicrob Agents Chemother; 1995 Feb; 39(2):553-5. PubMed ID: 7726532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of fluconazole concentrations in the prostatic and seminal vesicle fluid (split ejaculate).
    Schramm P; Wildfeuer A; Sarnow E
    Mycoses; 1994; 37(11-12):417-20. PubMed ID: 7659129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluconazole, with or without dexamethasone for experimental cryptococcosis: impact of treatment timing.
    Lortholary O; Nicolas M; Soreda S; Improvisi L; Ronin O; Petitjean O; Dupont B; Tod M; Dromer F
    J Antimicrob Chemother; 1999 Jun; 43(6):817-24. PubMed ID: 10404321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of Cryptococcus neoformans in the prostate: failure of fluconazole despite high doses.
    Bailly MP; Boibieux A; Biron F; Durieu I; Piens MA; Peyramond D; Bertrand JL
    J Infect Dis; 1991 Aug; 164(2):435-6. PubMed ID: 1856498
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility.
    Wildfeuer A; Laufen H; Schmalreck AF; Yeates RA; Zimmermann T
    Mycoses; 1997 Nov; 40(7-8):259-65. PubMed ID: 9476508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study of prostatic tissue levels of latamoxef, cefoperazone and cefotaxime].
    Takeuchi N; Kinukawa T; Matsuura O; Hattori R; Hasegawa S; Ohshima S; Ono Y
    Hinyokika Kiyo; 1986 Dec; 32(12):1831-41. PubMed ID: 2435132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ceftazidime concentration in human prostatic tissue and serum following intravenous injection].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1991 Jun; 37(6):659-62. PubMed ID: 1716410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study on fluconazole (FLCZ) in the treatment of primary pulmonary cryptococcosis].
    Hayashi Y; Ito G; Takeyama S
    Kansenshogaku Zasshi; 1998 Dec; 72(12):1261-8. PubMed ID: 9916411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some pharmacokinetic indices of oral fluconazole administration to koalas (Phascolarctos cinereus) infected with cryptococcosis.
    Govendir M; Black LA; Jobbins SE; Kimble B; Malik R; Krockenberger MB
    J Vet Pharmacol Ther; 2016 Aug; 39(4):412-5. PubMed ID: 26667113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics/pharmacodynamic correlations of fluconazole in murine model of cryptococcosis.
    Santos JR; César IC; Costa MC; Ribeiro NQ; Holanda RA; Ramos LH; Freitas GJ; Paixão TA; Pianetti GA; Santos DA
    Eur J Pharm Sci; 2016 Sep; 92():235-43. PubMed ID: 27235581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current progress in antifungal therapy: the value of fluconazole].
    Meunier F
    Rev Med Brux; 1990 Sep; 11(7):278-82. PubMed ID: 2218209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of lomefloxacin into human prostatic tissue.
    Leroy A; Humbert G; Fillastre JP; Grise P
    Am J Med; 1992 Apr; 92(4A):12S-14S. PubMed ID: 1374582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. The California Collaborative Treatment Group.
    Haubrich RH; Haghighat D; Bozzette SA; Tilles J; McCutchan JA
    J Infect Dis; 1994 Jul; 170(1):238-42. PubMed ID: 8014509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of ofloxacin and norfloxacin concentration in prostatic tissues in patients undergoing transurethral resection of the prostate.
    Chen J; Chen RR; Huang HS
    J Formos Med Assoc; 2001 Aug; 100(8):548-52. PubMed ID: 11678006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cefixime concentration in human prostatic tissue following 3-days of administration].
    Morita M; Nakagawa H; Suzuki K
    Hinyokika Kiyo; 1991 Nov; 37(11):1581-4. PubMed ID: 1722638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptococcal prostatitis in a patient with Behçet's disease treated with fluconazole.
    Fuse H; Ohkawa M; Yamaguchi K; Hirata A; Matsubara F
    Mycopathologia; 1995 Jun; 130(3):147-50. PubMed ID: 7566068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of SCH39304 in murine cryptococcosis.
    Restrepo BI; Ahrens J; Graybill JR
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1242-6. PubMed ID: 2552903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and tissue concentrations of fluconazole and their correlation to breakpoints.
    Pittrow L; Penk A
    Mycoses; 1997; 40(1-2):25-32. PubMed ID: 9260478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Astromicin sulfate concentration in human prostatic tissue after an intramuscular injection].
    Morita M; Hasuda A
    Hinyokika Kiyo; 1988 Oct; 34(10):1865-8. PubMed ID: 2469325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lomefloxacin concentration in human prostatic tissue following 3-day administration].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1993 Jan; 39(1):97-9. PubMed ID: 7681621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.